Polaris Market Research
Varicose Vein Treatment Market Growth, Industry Share, Overview, 2025-2034
Inquire Before Buying Request Free Sample
Varicose Vein Treatment Market Growth, Industry Share, Overview, 2025-2034

Varicose Vein Treatment Market Size, Share, Trends, Industry Analysis Report: By Type (Endovenous Ablation, Sclerotherapy, and Surgical Ligation & Stripping), Products, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034

  • Published Date:Mar-2025
  • Pages: 116
  • Format: PDF
  • Report ID: PM3848
  • Base Year: 2024
  • Historical Data: 2020-2023

Varicose Vein Treatment Market Overview

The varicose vein treatment market size was valued at USD 1.42 billion in 2024. The market is projected to grow from USD 1.51 billion in 2025 to USD 2.61 billion by 2034, exhibiting a CAGR of 6.3% during 2025–2034.

The varicose vein treatment market focuses on medical interventions aimed at alleviating the symptoms and appearance of varicose veins, which are enlarged, swollen veins that commonly affect the legs. Varicose vein treatment includes procedures such as sclerotherapy, laser therapy, endovenous laser treatment, and vein stripping. Key drivers of market growth are the increasing prevalence of varicose veins due to aging populations and sedentary lifestyles, rising awareness about minimally invasive treatment options, and advancements in medical technology. Varicose vein treatment market trends show a shift toward noninvasive procedures, with laser and radiofrequency ablation becoming more popular due to their lower recovery times and fewer complications. Additionally, growing consumer preference for cosmetic procedures and the expanding availability of these treatments in clinical and outpatient settings are contributing to the market expansion.

To Understand More About this Research: Request a Free Sample Report

Varicose Vein Treatment Market Dynamics

Growing Prevalence of Varicose Veins

The increasing prevalence of varicose veins, especially among aging populations, is a major driver of the varicose vein treatment market growth. As individuals age, the veins naturally weaken and become less efficient in returning blood to the heart, leading to conditions such as varicose veins. According to the American Vein & Lymphatic Society, nearly 25% of adults suffer from varicose veins, with the condition being more common among women than men. The rising aging population across the world is expected to increase the number of varicose vein cases, thereby propelling the demand for effective treatment options. Additionally, lifestyle factors such as long periods of sitting or standing, which are more prevalent in modern work environments, exacerbate the condition, fueling the need for timely treatments.

Shift Toward Minimally Invasive Treatments

Traditional surgical treatments, such as vein stripping, are associated with longer recovery times and higher complication rates. In contrast, procedures such as sclerotherapy, endovenous laser therapy, and radiofrequency ablation are gaining popularity due to their ability to offer effective results with minimal downtime and fewer risks. A study published in the Journal of Vascular Surgery found that endovenous laser ablation has a success rate of over 90%, making it an increasingly sought-after option. This shift toward noninvasive treatments is improving patient outcomes and catering to a larger, more diverse patient base. Hence, the rising shift toward minimally invasive treatments boosts the varicose vein treatment market demand.

Rising Awareness and Demand for Cosmetic Procedures

The increasing awareness surrounding varicose vein treatments, especially in terms of their cosmetic benefits, is driving varicose vein treatment market development. While varicose veins are often seen as a medical issue, many individuals also seek treatment for aesthetic reasons. The desire to improve the appearance of the legs is a significant motivator, especially in regions where social perceptions place importance on physical appearance. A survey conducted by the American Society for Dermatologic Surgery revealed that ∼60% of participants were motivated to seek treatment for varicose veins primarily due to cosmetic concerns. As cosmetic procedures become more accessible, the number of individuals opting for varicose vein treatment is steadily rising.

Varicose Vein Treatment Market Segment Insights

Varicose Vein Treatment Market Assessment – Type-Based Insights

The varicose vein treatment market, by type, is segmented into endovenous ablation, sclerotherapy, and surgical ligation & stripping. The endovenous ablation segment, which includes laser and radiofrequency ablation, holds the largest market share due to its noninvasive nature and effectiveness. This segment is experiencing significant growth, driven by advancements in technology that have enhanced the precision and success rates of these procedures. The popularity of endovenous ablation is further supported by its ability to offer a quicker recovery time and lower risk of complications compared to traditional surgical methods, making it the preferred choice for patients and healthcare providers. Sclerotherapy, another noninvasive option, remains widely used, especially for smaller varicose veins. The sclerotherapy segment continues to register steady demand, though it is not growing as rapidly as endovenous ablation. The surgical ligation & stripping segment, while still in use for severe cases, is gradually losing market share due to its more invasive nature and longer recovery times.

The endovenous ablation segment is projected to maintain the highest growth rate in the coming years, driven by increased patient preference for minimally invasive treatments and the ongoing development of more advanced techniques. The efficiency and safety profile of endovenous ablation procedures are key factors fueling their adoption. Additionally, the segment benefits from the growing awareness of the benefits of minimally invasive options. Sclerotherapy and surgical ligation & stripping segment will continue to serve specific niches within the market, with sclerotherapy remaining a staple for smaller veins and surgical methods being applied to more complex or severe cases that do not respond well to noninvasive treatments.

Varicose Vein Treatment Market Outlook – End Use-Based Insights

The varicose vein treatment market, by end use, is segmented into vein clinics, hospitals, and ambulatory care units. The vein clinics segment holds the largest market share, driven by their specialized focus on vascular conditions, including varicose veins. These clinics are equipped with advanced technologies for minimally invasive treatments such as endovenous ablation and sclerotherapy, which are increasingly preferred by patients due to their convenience and lower recovery times. Vein clinics offer a focused, patient-centered approach, contributing to their dominant position in the market. This segment is also benefiting from the growing demand for outpatient procedures that offer faster recovery and reduced hospitalization time.

The ambulatory care unit segment is registering the highest growth, primarily due to the increasing preference for outpatient treatments that allow patients to undergo procedures and return home on the same day. With a growing emphasis on reducing healthcare costs and providing efficient, quick treatments, ambulatory care units are becoming more prominent for varicose vein procedures. These units cater to patients seeking affordable and accessible care, which is contributing to their rapid growth. Hospitals, while still a significant segment, are seeing relatively slower growth compared to vein clinics and ambulatory care units due to the rising trend toward outpatient care and less invasive treatment options. However, the hospitals segment continues to serve patients with more complex cases that require comprehensive medical attention.

Varicose Vein Treatment Market Regional Analysis

By region, the study provides varicose vein treatment market insights into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America holds the largest share of the global varicose vein treatment market revenue, primarily due to the high prevalence of varicose veins, a well-established healthcare infrastructure, and a strong preference for minimally invasive treatments. The region's advanced medical technologies, high patient awareness, and availability of specialized vein clinics contribute to its dominance. Additionally, the aging population and increasing demand for cosmetic procedures in countries, such as the US, fuel the varicose vein treatment market expansion. Europe also holds a significant share, driven by a similar healthcare environment like North America and rising preference for noninvasive procedures. Meanwhile, Asia Pacific is expected to experience the highest growth rate, attributed to increasing healthcare access, growing awareness, and expanding adoption of advanced treatment methods in emerging markets. The market in Latin America and the Middle East & Africa is witnessing steady growth, supported by improving healthcare infrastructure and rising disposable incomes.

Europe is one of the key regions in the varicose vein treatment market, driven by a combination of factors such as an aging population, high healthcare standards, and increasing patient awareness about varicose vein treatments. Countries such as Germany, the UK, and France are leading in terms of varicose vein treatment market share due to advanced healthcare facilities, specialized clinics, and the growing preference for minimally invasive procedures such as sclerotherapy and endovenous ablation. The rise in the cosmetic appeal of varicose vein treatments, along with the increasing availability of advanced technologies, is further propelling market growth in Europe. Furthermore, the region benefits from a well-established regulatory framework and favorable reimbursement policies for varicose vein treatments, encouraging patients to seek medical attention.

The Asia Pacific varicose vein treatment market is experiencing rapid growth, fueled by an upsurging population of senior citizens, improving healthcare infrastructure, and increasing awareness of varicose vein treatments. Countries such as Japan, China, and India are seeing higher adoption of minimally invasive procedures due to technological advancements and rising healthcare accessibility. The demand for medical and cosmetic treatments is growing, as more individuals are opting for effective solutions to manage varicose veins. The growing focus on healthcare affordability, especially in emerging markets, along with increasing awareness of the benefits of noninvasive procedures, is expected to drive the market’s expansion in this region. The Asia Pacific market is poised for significant growth in the coming years, supported by a large patient pool and increasing healthcare investments.

Varicose Vein Treatment Market – Key Players and Competitive Insights

One of the key players in the varicose vein treatment market includes Medtronic, a player offering advanced technologies for minimally invasive procedures, including the ClosureFast system for endovenous radiofrequency ablation. Boston Scientific Corporation provides comprehensive solutions in varicose vein treatment, particularly through its VenaCure EVLT laser treatment system. AngioDynamics offers products such as the Venacure laser and is involved in minimally invasive procedures for vascular conditions. Biolitec AG is known for its high-performance laser technologies such as ELVeS laser system for varicose vein treatments. Cook Medical, a global medical device company, offers various interventional radiology tools, including those for varicose vein treatment.

Other notable companies include Sotrastan, a supplier of medical devices for vascular surgery, with a focus on minimally invasive procedures. Lumenis Ltd. is another key player, offering laser technologies for varicose vein treatments. Medtronic's subsidiary Covidien produces vascular interventions, contributing to the development of innovative solutions. Teleflex Incorporated provides a broad portfolio of vascular products, including those used for varicose vein treatment. Vascular Insights is known for its Clarivein mechanical catheter for endovenous ablation and provides solutions for vein-related conditions. Sciton Inc. offers laser systems for vascular treatments, including varicose veins, while Quanta System S.p.A. is involved in laser technology solutions for the treatment of varicose veins.

The varicose vein treatment market is characterized by a mix of established and emerging players focusing on innovation and product development to cater to the growing demand for minimally invasive treatments. Companies such as Medtronic, Boston Scientific, and AngioDynamics dominate the market with a wide range of technological solutions and established healthcare networks. However, smaller players such as Sciton and Teleflex are increasing their presence through specialized offerings that focus on enhancing patient outcomes with innovative treatment options. The competition in the market remains intense, with players investing heavily in research and development to introduce new solutions that reduce recovery times and improve treatment efficacy. There is also a growing trend toward partnerships and collaborations, enabling these companies to expand their reach and enhance their treatment portfolios in a market driven by rising demand for medical and cosmetic vein treatments.

Medtronic is a prominent player in the varicose vein treatment market, offering a range of products focused on minimally invasive procedures. The company provides the ClosureFast system for endovenous radiofrequency ablation, which is widely used in treating varicose veins. Medtronic’s presence in the market is strengthened by its global healthcare network and broad portfolio of medical technologies.

Boston Scientific Corporation is another key player in the varicose vein treatment market, offering various products and solutions for the treatment of venous conditions. Their VenaCure EVLT laser treatment system is commonly used for endovenous laser ablation. The company focuses on providing minimally invasive medical technologies that improve patient outcomes.

List of Key Companies in Varicose Vein Treatment Market

  • AngioDynamics
  • Biolitec AG
  • Boston Scientific Corporation
  • Cook Medical
  • Covidien (a Medtronic subsidiary)
  • EndoShape
  • Lumenis Ltd.
  • Medtronic
  • Quanta System S.p.A.
  • Sciton Inc.
  • Sotrastan
  • Teleflex Incorporated
  • Vascular Insights
  • VeinMed Inc.

Varicose Vein Treatment Industry Developments

  • In December 2024, Boston Scientific received FDA approval for its new venous procedure, expanding its portfolio in the vascular space. This approval is expected to enhance its market position by offering advanced treatment options to patients seeking effective solutions for varicose veins.
  • In November 2024, Medtronic announced the acquisition of Mazor Robotics, enhancing its capabilities in robotic-assisted surgery, which may indirectly impact its vascular treatment offerings by integrating advanced robotic technology in its procedures.

Varicose Vein Treatment Market Segmentation

By Type Outlook (Revenue – USD Billion, 2020–2034)

  • Endovenous Ablation
  • Sclerotherapy
  • Surgical Ligation & Stripping

By Products Outlook (Revenue – USD Billion, 2020–2034)

  • Ablation Devices
  • Radiofrequency Ablation Devices
  • Laser Ablation Devices
  • Venous Closure Products

By End Use Outlook (Revenue – USD Billion, 2020–2034)

  • Vein Clinics
  • Hospitals
  • Ambulatory Care Unit

By Regional Outlook (Revenue – USD Billion, 2020–2034)

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Netherlands
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Malaysia
    • South Korea
    • Indonesia
    • Australia
    • Vietnam
    • Rest of Asia Pacific
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Israel
    • South Africa
    • Rest of Middle East & Africa
  • Latin America
    • Mexico
    • Brazil
    • Argentina
    • Rest of Latin America

Varicose Vein Treatment Market Report Scope

Report Attributes

Details

Market Size Value in 2024

USD 1.42 billion

Market Size Value in 2025

USD 1.51 billion

Revenue Forecast by 2034

USD 2.61 billion

CAGR

6.3% from 2025 to 2034

Base Year

2024

Historical Data

2020–2023

Forecast Period

2025–2034

Quantitative Units

Revenue in USD billion and CAGR from 2025 to 2034

Report Coverage

Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends

Segments Covered
  • By Type
  • By Product
  • By End Use

Regional Scope
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Competitive Landscape
  • Varicose Vein Treatment Industry Trends Analysis (2024)
  • Company Profiles/Industry participants profiling includes company overview, financial information, product/service benchmarking, and recent developments

Report Format
  • PDF + Excel

Customization

Report customization as per your requirements with respect to countries, regions, and segmentation.

How is the report valuable for an organization?

Workflow/Innovation Strategy: The varicose vein treatment market has been segmented on the basis of type, product, and end use. Moreover, the study provides the reader with a detailed understanding of the different segments at both the global and regional levels.

Growth/Marketing Strategy: The varicose vein treatment market growth and marketing strategies focus on expanding product portfolios, increasing patient awareness, and enhancing treatment accessibility. Companies are investing in research and development to innovate minimally invasive procedures that offer quicker recovery times and better outcomes. Strategic partnerships, collaborations, and acquisitions are being pursued to broaden geographical reach and integrate advanced technologies into treatment offerings. Additionally, digital marketing campaigns and educational content are being used to raise awareness about varicose vein treatments, targeting medical professionals and patients. Companies are also focusing on improving the affordability and availability of treatments to cater to a broader demographic

FAQ's

The varicose vein treatment market size was valued at USD 1.42 billion in 2024 and is projected to grow to USD 2.61 billion by 2034.

The market is projected to register a CAGR of 6.3% during the forecast period.

North America held the largest share of the market in 2024.

A few key players in the varicose vein treatment market are Medtronic, Boston Scientific Corporation, AngioDynamics, Biolitec AG, Cook Medical, Sotrastan, Lumenis Ltd., Covidien (a Medtronic subsidiary), and Teleflex Incorporated.

The varicose vein treatment market report covering key segments are treatment mode, products, end user and region.

Varicose vein treatment refers to medical procedures aimed at alleviating the symptoms and improving the appearance of varicose veins, which are enlarged, twisted veins that typically occur in the legs. These veins are caused by weakened or damaged valves that prevent proper blood flow. Treatment options include minimally invasive procedures such as sclerotherapy (injection of a solution to close the vein), endovenous laser ablation (using laser energy to seal the vein), and radiofrequency ablation. Traditional methods, such as surgical ligation and stripping, are also used in severe cases. The goal of treatment is to reduce discomfort, prevent complications, and improve cosmetic appearance.

A few key trends in the market are described below: Minimally Invasive Treatments: Increased preference for noninvasive procedures such as endovenous laser ablation, radiofrequency ablation, and sclerotherapy due to shorter recovery times and fewer complications. Technological Advancements: Continuous innovations in treatment technologies, including improved laser systems, radiofrequency energy devices, and catheter-based therapies. Cosmetic Focus: Rising demand for varicose vein treatments driven by cosmetic concerns, as more people seek solutions for aesthetic reasons alongside medical benefits. Outpatient Care: Growing shift toward outpatient procedures, with a preference for treatments offered in vein clinics and ambulatory care units rather than hospitals.

A new company entering the varicose vein treatment market must focus on offering innovative, minimally invasive treatment options that prioritize patient comfort and faster recovery times. Investing in advanced technologies, such as next-generation laser systems or radiofrequency devices, could differentiate the company by improving treatment efficiency and outcomes. Additionally, targeting underserved markets, including emerging regions with growing healthcare access, could provide significant growth opportunities. Building strong relationships with healthcare professionals and establishing specialized vein clinics would also enhance credibility. Further, focusing on patient education and offering comprehensive support services can strengthen brand loyalty and attract a wider patient base.

© 2025 Polaris Market Research and Consulting. All rights reserved

paypal